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Clinical olfactory tests are used to address hyposmia/anosmia levels in patients with
different types of olfactory impairments. Typically, a given test is employed clinically and
then replaced by a new one after a certain period of use which can range from days to
several months. There is a need to assess control quality of these tests and also for a
procedure to quantify their degradation over time. In this paper we propose a protocol
to employ low-cost artificial noses for the quantitative characterization of olfactory tests
used in clinical studies. In particular, we discuss a preliminary study on the Connecticut
Chemosensorial Clinical Research Center Test kit which shows that some odorants, as
sensed by an artificial nose, seem to degrade while others are potentiated as the test
ages. We also discuss the need to establish a map of correspondence between human
and machine olfaction when artificial noses are used to characterize or compare human
smell performance in research and clinical studies.
Keywords: electronic noses, quality control of clinical olfactory tests, map of human and machine olfaction,
olfaction, anosmia, olfactory dysfunction, artificial noses
INTRODUCTION
The assessment of olfactory function is an essential step for the
diagnosis and treatment of olfactory disabilities. In particular,
the quantification of the olfaction functional level is necessary
to assess the recovery from or the progression of the smell dys-
function. The link between some types of smell impairments
and the early detection of neurodegenerative (Albers et al., 2006;
Barrios et al., 2007; Doty, 2008) or psychiatric (Atanasova et al.,
2008) diseases also emphasizes the need of precise olfactory quan-
tification procedures. Different protocols like the Connecticut
Chemosensory Clinical Research Center (CCCRC) test (Cain,
1989), the University of Pennsylvania Smell Identification Test
(UPSIT) (Doty et al., 1984), Sniffin’ Sticks (Burghart, Wedel,
Germany) (Hummel et al., 1997), T&T olfactometry, or the Odor
Stick Identification Test for Japanese (OSIT-J) (Zusho, 1983)
are employed throughout the world to assess the sense of smell
in patients with different cultural backgrounds and disabilities.
These tests consist of different odor containers that are presented
to a patient to quantify specific odor thresholds, and to evaluate
odor identification and discrimination.
A given test sample is typically employed in the clinic and then
replaced by a new one after a certain period of use. In many cases
the sample is opened, used, and closed again over an extended
period of timewhich can range fromdays to severalmonths. Thus,
there is a need to assess control quality of these test samples and
to establish a protocol to quantify their degradation over time.
Artificial noses are devices that use one or multiple sensors
to mimic the sense of smell. The sensor reacts to an odorant
and generates a signal that can be used for characterization,
discrimination, or recognition purposes. The first artificial nose
with a tin-oxide sensor was reported in the early 1980s. A wide
range of sensor technologies have been developed since them to
build many different types of artificial noses: electrical, gravimet-
ric, optical, etc., [for a review of sensor technologies for artificial
noses see (Stitzel et al., 2011)]. The applications of artificial noses
cover areas such as safety, security, food, and beverage qual-
ity control, environmental monitoring, medical diagnostics, etc.,
(Dymerski et al., 2011; Stitzel et al., 2011).
In the following sections we propose the use of low-cost artifi-
cial noses to quantitatively characterize olfactory tests for clinical
studies, and we discuss a preliminary study on the CCCRC kit.
We also discuss the need to establish a map between human and
machine olfaction for research and clinical studies.
MATERIALS AND METHODS
CONNECTICUT CHEMOSENSORIAL CLINICAL RESEARCH CENTER TEST
The CCCRC kit was developed by Cain and colleagues in 1988.
This test consists of two parts: the butanol threshold test and the
identification test. For the purposes of this study we will mainly
concentrate on the butanol threshold test. The test was manu-
factured at Hospital Fundación de Alcorcón, Madrid with the
collaboration of the Pharmacy Unit following the guidelines of
the original article. The threshold test employs aqueous dilutions
of 1-butanol where successive dilutions differ by a factor of three.
The highest aqueous concentration is 4%. The number of dilu-
tion steps ranges from 0 to 8 depending on testing circumstances.
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FIGURE 1 | The Connecticut Chemosensorial Clinical Research Center
Test used in this study. The brown bottles contain the butanol threshold
test, while the white plastic jars contain the identification test.
The test solutions were stored in 125ml polyethylene bottles
containing 60ml of solution which are presented to patients dur-
ing the test. The bottle closure has a pop-up spout that fits
to both nostrils (see Figure 1). To sample a bottle, the per-
son places the spout into both nostrils and then sniffs. There
are two common ways to present the stimulus: the ascending
method of limits (AMLs) procedure and the single staircase (SS)
procedure. In the AML, the odorant and the water are pre-
sented sequentially from low to high concentration and the
point of transition between no detection and detection is esti-
mated. In the SS method, the concentration of the stimulus is
increased following trials in which correct detection occurs. In
both methods, the stimulus is presented in order from weak
to strong. The SS procedure is more reliable and is used more
often for threshold testing. Four correct choices in a row lead to
end the test. The concentration at which this occurs marks the
threshold.
Recently, Toledano and colleagues have described a short olfac-
tory test based on CCCRC that predicts how severe is the smell
loss (Toledano et al., 2009). This short test consists on deter-
mining the lowest concentration of butanol that the patient
can detect four times in a row. Patients detecting beyond the
butanol dilution number 3 have a high probability of normal
olfaction.
The participant receives the identification test after the thresh-
old test. The identification kit is composed of ten 180ml opaque
plastic jars containing 5 g of the substance in sachet-like packets
of stimuli. Based on the performance of anosmic patients, we can
ascertain that seven stimuli appeal almost exclusively to the sense
of smell (baby powder, chocolate, cinnamon, coffee, mothballs,
peanut butter, and bar soap) and one appeals to the trigemi-
nal sense as well (Vicks). These eight items are presented in the
same order to both nostrils. When presented with an item, the
patient chooses from a 20-item list. The list contains the names
of the eight test products and 13 distractors. In addition to the
names on the list, responses of “no sensation” and “do not know”
are permitted. The examiner provides corrective feedback when-
ever the participant makes an error. If the participant exhibits
some evidence of function, but nevertheless makes mistakes,
the examiner presents missed items for a second time. A cor-
rect answer upon a second presentation cancels a previous error.
This allows the patient to rectify mistakes and thereby decreases
the possibility of cognitive errors. In such cases, the first trial
with an item serves as training. The score for the test comprises
the number of olfactory items out of seven correctly identi-
fied and a notation regarding the ability to perceive trigeminal
stimulation.
The outcome of the threshold and the identification tests is
combined into a composite score, an average of the two tests. As
previously defined (Toledano et al., 2003), a score of 5 points or
more indicates normosmia, a score between 2 and 4.5 points indi-
cates reduced olfactory function in terms of hyposmia, and a score
of less than 2 points indicates functional anosmia.
To categorize progression of olfactory function, a subjective
improvement and a normal score in butanol, threshold and
composite, respectively, are regarded as a clinically significant
improvement of olfactory function. Its correlation with previ-
ously established tests of olfactory function (e.g., the 12-item
Cross-Cultural Smell Identification Test [CC-SIT, a subtest of the
UPSIT] and the “Sniffin’ Sticks” test) has been demonstrated in
various studies (Kobal et al., 2000; Toledano et al., 2007).
ARTIFICIAL NOSES FOR QUALITY CONTROL OF OLFACTORY TESTS
During the last decades artificial nose technology has provided
many successful examples of industrial applications [for recent
reviews see (Dymerski et al., 2011; Stitzel et al., 2011)]. As this
technology becomes cheaper andmore accessible, the possibilities
of potential use inmedical and clinical studies have also increased.
In this section we discuss a preliminary study on the use of a
low-cost, portable artificial nose to quantitatively characterize the
CCCRC test.
For the study reported in this paper we used an odor analy-
sis platform capable of managing up to 16 samples with on/off
control electrovalves and three auxiliary devices such as pumps,
heaters, and/or mixers (see Figure 2). Although the platform can
be equipped with a wide variety of sensor arrays, we aimed to
study the performance of inexpensive sensors that could be used
FIGURE 2 | Analysis platform used in this study with the TGS2600-B00
(Figaro Engineering Inc.) chemoresistive sensor.
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in future widely distributed control quality devices. Thus, we
selected the TGS2600-B00 (Figaro Engineering Inc.) chemoresis-
tive sensor. This small sensor also provides a good combination of
high sensitivity to low concentrations of odorants, long life, low
power consumption, and robustness. The sensor is comprised of
a metal oxide semiconductor layer formed on an alumina sub-
strate of a sensing chip together with an integrated heater. In the
presence of an odorant, the sensor’s conductivity increases as a
function of the concentration. A simple electrical circuit converts
the change in conductivity to an output signal that corresponds
to the odorant. The signal generated by the sensor is not ampli-
fied, it is only conditioned with an LMC6484 amplifier in voltage
follower mode and sent to the Analog-to-Digital (A/D) converter
module to be acquired and stored in a computer. The voltage
range of this signal is 0–5V.
From the control point of view, the main component used in
this platform is an 8-bit PIC18F2455 microcontroller (Microchip
Technology Inc.). This microcontroller is ideal for low-cost, low
power (nano-Watt), and connectivity applications. The firmware
was programmed with the MPLAB IDE development environ-
ment provided by the same company. The computer application
software was developed with IDE Dev-C++ (GNU license) using
Windows APIs. The equipment is connected to a PC via serial
bus, by a proprietary protocol based on EIA-485. The transfer rate
used in our study was 100 samples per second. For this applica-
tion we used the rotary vane pump 01-K G-LC (Rietschle Thomas
Company) in continuous vacuum mode (−20 mbar max.) run-
ning at 80% of its nominal voltage. All the instrumentation used
in this study is characterized by its compactness and low price,
which are important factors for a wide dissemination of quality
control in olfactory tests.
Since the goal of our experiments is to assess the degradation
of well-known odorants, we used the peak of the sensor signal
to characterize the dilutions/odorants in a comparative manner
(the peak corresponding to an aged olfactory test vs. the peak
corresponding to a new test). The maximal separability between
signals occurs typically at the peak. This is a simple and straight-
forward measurement that does not require further processing of
the signal.
The performance of the TGS2600-B00 sensor has a mod-
erate ambient temperature/humidity dependence as described
in the manufacturer’s worksheet (http://www.figarosensor.com/
products/2600pdf.pdf). All experiments reported here were per-
formed at a room temperature between 23◦C and 24◦C and a
humidity of 30–35%. The acquisition of the signal was performed
with the following protocol: the sensor was exposed to room air
with no heating (OV) for 5 s, followed by 100 s at maximum heat-
ing (4.8 V) to clean the sensor (heater resistance is 83). After
this cleaning phase, we took 5 s of absorption of the odorant
(4.8 V for heating, this duration was chosen to avoid saturation),
and finally 100 s of desorption (room air again at maximum heat-
ing). Five consecutive measurements of all odorants were taken
following this protocol to avoid history dependent effects.
RESULTS
The quality control assessment of a clinical olfactory test can use
the quantitative comparison of the artificial nose characterization
of a brand new test and that of a test that has been used for a
certain period of time. Here, we propose a simple quality anal-
ysis that consists on the quantitative assessment by the artificial
nose of a dilution in the test as compared with the correspond-
ing next dilution of a new test. A given olfactory kit fails the
quality test when the response of the artificial nose for a dilu-
tion is close to the response obtained for the next dilution
in the new test, which contains a lower concentration of the
odorant.
As mentioned above, a short version of the CCCRC kit con-
sists in the presentation of dilution number 3. Patients who
cannot smell this dilution have a very high probability of olfac-
tory dysfunction (Toledano et al., 2009). To illustrate and test the
proposed quality protocol with the artificial nose, we will use dilu-
tions number 2, 3, and 4 of the CCCRC threshold kit. Dilution
2 has a higher concentration of butanol than dilution 3, while
dilution 4 has a lower concentration.
Figure 3 shows the response of the artificial nose to these dilu-
tions corresponding to a one year old test (labeled as O for old)
and to a new test (labeled as N). This figure illustrates that, after
one year, the sensor signal that corresponds to the old dilution
number 2 (2O) differs only slightly from the corresponding to
the new dilution (2N) and remains far from the signal of the new
dilution number 3 (3N). However, the signal corresponding to the
old dilution number 3 (3O) is nearly as close to the signal corre-
sponding to new dilution number 4 (4N) as to the new dilution
number 3 (3N). Thus, as sensed by the artificial nose, dilution 3O
could correspond to the next dilution (lower concentration) of a
new test. In this situation, a quality control criteria based in the
relative distance between the peaks of the signals would result in
discarding the old test kit.
For each dilution, the maximum peak is reached a little after
the stimulation is stopped. We remind that the protocol that we
follow uses five consecutive measurements of the same odorant
FIGURE 3 | Response of the artificial nose to three dilutions of the
CCCRC kit for two different sets: a kit that has been used for over one
year (dilutions labeled as 2O, 3O, and 4O) and a new one (dilutions
labeled as 2N, 3N, and 4N). For each dilution we show the mean of five
measurements (middle trace) together with the standard deviation (upper
and lower traces). Note that the artificial nose signal for dilution 3O is nearly
as close to 3N as to 4N. A quality control criteria based in the relative
distance between the peaks of the signals would result in discarding the
old test kit.
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to avoid history dependent effects between different odorants.
Note that we use the same desorption period for all of them and
odorants that reach a higher maximum also start from a slightly
higher baseline in this protocol.
We have also addressed the analysis with the artificial nose of
the identification kit that the subject receives after the threshold
kit in the CCCRC test. The purpose of this second kit is the eval-
uation of the ability to identify an odor. Thus, the analysis of the
artificial nose in this case is oriented to determine the stability of
the odorant over time. If the odorant changes significantly over
the lifespan of the kit (typically one year), this could result in the
lack of identification or in a wrong identification of the odorant
by the subject. Figure 4 shows the result of this analysis for two
odorants (coffee and peanut butter). The aged tests (used clini-
cally for more than one year) show a larger intensity as sensed by
the artificial nose. The odorants in this identification kit are hid-
den under a gauze pad. The increase in signal amplitude observed
in these aged jars is probably due to a degenerative chemical reac-
tion or the presence of bacteria in the sample and in the pad
because of the prolonged use of the kit. The rest of the odorants
in the identification kit present a normal degradation as sensed by
the electronic nose.
DISCUSSION
The precise quantification of olfactory perception is an essential
step for the evaluation, diagnosis, and treatment of smell disor-
ders and contributes to the success of a corresponding therapy.
In the last decades several olfactory tests have been proposed
to quantify odor thresholds and to evaluate human odor iden-
tification and discrimination. In this paper we have argued that
olfactory tests could benefit from quality control performed by
artificial noses to assess and guarantee their validity over their
lifespan.
We have proposed a protocol to test the quality of a thresh-
old clinical kit by comparing the response of the artificial nose
to a given dilution of the test with the immediate next dilution
FIGURE 4 | Response of the artificial nose to two samples (peanut
butter—left panel and coffee—right panel) of the identification part of
the CCCRC kit. For each sample we show the mean of five measurements
(middle trace) together with the standard deviation (upper and lower
traces). Note that, as sensed by the artificial nose, the old peanut butter
(OP) and coffee jars (OC) have higher odor intensity than the ones that
contain a new test (NP and NC, respectively).
of a new test. We have validated this protocol with the CCCRC
threshold kit using an inexpensive chemoresistive sensor, which is
a requirement for the successful dissemination of a quality control
device for clinical purposes. The protocol does not need a com-
plex processing of the sensor signal such as the use of classification
or clustering algorithms required inmany applications with artifi-
cial noses (Hierlemann and Gutierrez-Osuna, 2008; Muezzinoglu
et al., 2010). As illustrated in Figures 3 and 4, the response of
the sensor to the odorants in the CCCRC kit is highly repro-
ducible. The comparative nature of the protocol (the results of
the artificial nose on an old test are always compared with those
of a new test) reduces the dependence of the results on sen-
sor drift and environmental conditions such as temperature and
humidity.
Human olfaction and machine olfaction have different mech-
anisms to sense smell, and thus the quantitative description of an
odorant can also be very different for human and artificial noses
(Burl et al., 2001; Schiffman et al., 2002; Lewis, 2004; Haddad
et al., 2008, 2010). When artificial noses are used to character-
ize or compare human smell performance, the signals obtained
with these devices need to be calibrated and matched to what is
considered a normal perception by a human. In the context of
clinical olfactory tests where the smell of odorants takes place
under controlled conditions, the quantitative description of an
odor by an artificial nose can be compared to an established
reference to assess the quality of the test. The results shown in
this paper indicate that this is possible, and that an inexpensive
chemoresistive sensor can be used to characterize the threshold
part of the Connecticut Chemosensorial Clinical Research Center
Test. We have also reported that some odorants of the identi-
fication part of the CCCRC seem to be potentiated as sensed
by the artificial nose while others tend to degrade as the test
grows older. The analysis of these results suggests that the con-
ditions to keep the odorants in the identification test could be
improved.
Further efforts to build a map between human and machine
olfaction can largely contribute to the assessment of odor per-
ception and to develop novel protocols for odor impairment
diagnosis and treatment. Artificial noses can be used to assess
the intensity, steadiness, or temporal evolution of an odorant
acting as a stimulus in a perception experiment. These exper-
iments can be carried out with a standard feedback from the
self-assessment of smell perception by the subject or through
a more quantitative protocol that takes into account levels of
brain activity in EEG (Lorig, 2000) and/or fMRI setups (Lombion
et al., 2009) (which can largely contribute to a quantitative map
between human and machine olfaction). In all cases, the assess-
ment of odor temporal structure and intensity by artificial noses
will improve the quantification and the standardization criteria
in these protocols. In addition, artificial noses can also be used in
closed-loop experiments with olfactometers and other stimula-
tion devices to implement neural activity-dependent stimulation
protocols.
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